[Evaluation of cytosine arabinoside therapy in congenital cytomegalovirus diseases].
D003561:Cytarabine / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D005260:Female; D006529:Hepatomegaly / Q000150:complications; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D008297:Male; D013163:Splenomegaly / Q000150:complications
D003561:Cytarabine
Beurteilung der Cytosinarabinosid-Behandlung bei congenitalen Cytomegalieerkrankungen.